Where options run out, BRIA-ABC bets on survival in metastatic breast cancer

Summary

A Clinical Trials Arena piece citing GlobalData analysis notes that metastatic breast cancer trial activity remains high but is still concentrated in Phase I and II studies, and discusses BRIA-ABC's focus on survival in patients with limited remaining options. The article excerpt provides no specific trial results or company details.